UK guidelines on 18F-fluciclovine PET/CT in prostate cancer imaging

Nucl Med Commun. 2019 Jul;40(7):662-674. doi: 10.1097/MNM.0000000000001030.

Abstract

The purpose of these guidelines is to assist specialists in Nuclear Medicine and Radionuclide Radiology in recommending, performing, interpreting and reporting F-fluciclovine PET/computed tomography. It should be recognised that adherence to the guidance in this document will not assure an accurate diagnosis or a successful outcome. These guidelines will assist individual departments in the formulation of their own local protocols. The guidelines apply to studies on adults. All that should be expected is that the practitioner will follow a reasonable course of action based on current knowledge, available resources and the needs of the patient in order to deliver effective and safe medical care.

MeSH terms

  • Carboxylic Acids*
  • Cyclobutanes*
  • Humans
  • Image Processing, Computer-Assisted
  • Injections
  • Male
  • Neoplasm Staging
  • Positron Emission Tomography Computed Tomography*
  • Practice Guidelines as Topic*
  • Prostatic Neoplasms / diagnostic imaging*
  • Prostatic Neoplasms / pathology
  • Radiation Exposure / prevention & control
  • United Kingdom

Substances

  • Carboxylic Acids
  • Cyclobutanes
  • fluciclovine F-18